Consultation with Dr. Sneha Shrestha to:
- Comprehensively review genetics, labs, and hormones
- Order any additional functional labs
- Prepare for your Spravato treatment protocol and set intentions
Spravato is the first FDA-approved form of intranasal ketamine to rapidly relieve treatment-resistant depression
Spravato is a transformational, FDA-approved treatment for:
Learn more about the difference between Spravato and IV ketamine therapy for mental health and chronic pain.
We accept Aetna, Cigna, Medicare, and Anthem Blue Cross Blue Shield insurances for Spravato.
Compare the different ketamine routes to see the difference with Clarus Health
Rapid relief from depression, anxiety, and PTSD comes in 3 stages
Consultation with Dr. Sneha Shrestha to:
Your treatment plan includes:
Most patients begin experiencing relief within 1-4 sessions. Most insurance plans provide several months of Spravato coverage.
Additional months of coverage may be provided based on treatment response
Watch Alex's live Ketamine journey with Dr. Kaveh at Clarus Health
Drs. Anthony Kaveh and Sneha Shrestha have led thousands of ketamine infusion experiences. They are Stanford and Harvard-trained physicians who guide patients to uncover their inner healing capacity and rediscover meaning and purpose as part of a holistic healing journey.
Learn from our expert physicians about IV ketamine therapy for depression, anxiety, chronic pain, and PTSD.